MeOSuc-AAPV-AFC integrates a methoxysuccinyl-protected peptide sequence with a fluorogenic AFC group for monitoring enzymatic cleavage. Residue selection supports protease-recognition studies and kinetic profiling. Researchers assess fluorescence changes to characterize catalytic behavior. Uses include substrate-validation assays, enzyme-mechanism mapping, and biochemical method development.
CAT No: R2338
CAS No:125791-90-4
Synonyms/Alias:MeOSuc-AAPV-AFC;Meosuc-Ala-Ala-Pro-Val-7-Amino-4-Trifluoro-Methylcoumarin;FLFLPZJVJVKNIW-BYRWETQCSA-N;HY-P5374;DA-55339;CS-0882855;125791-90-4;methyl 4-((S)-1-((S)-1-((S)-2-((S)-3-methyl-1-oxo-1-(2-oxo-4-(trifluoromethyl)-2H-chromen-7-ylamino)butan-2-ylcarbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-1-oxopropan-2-ylamino)-4-oxobutanoate;
MeOSuc-AAPV-AFC, also known as Methoxysuccinyl-Ala-Ala-Pro-Val-7-amino-4-trifluoromethylcoumarin, is a synthetic peptide substrate widely recognized for its utility in enzymatic activity assays, particularly those involving serine proteases such as neutrophil elastase. This compound features a peptide sequence that is selectively cleaved by target proteases, releasing the highly fluorescent 7-amino-4-trifluoromethylcoumarin (AFC) moiety upon hydrolysis. The resulting fluorescence can be quantitatively measured, offering a sensitive and reliable method for monitoring enzyme kinetics and inhibitor screening. Because of its specificity and robust signal generation, MeOSuc-AAPV-AFC is extensively employed in biochemical research settings where accurate detection and quantification of protease activity are critical. Its design enables researchers to achieve real-time monitoring of enzymatic processes, facilitating a deeper understanding of protease function and regulation in various biological systems.
Enzyme Activity Assays: MeOSuc-AAPV-AFC is predominantly utilized in the development and execution of enzyme activity assays, especially for serine proteases like neutrophil elastase. By incorporating this substrate into in vitro assay systems, researchers can directly observe the rate of substrate cleavage through the increase in fluorescence intensity as AFC is liberated. This approach allows for precise kinetic analyses, enabling the determination of catalytic parameters such as Km and Vmax, and supporting the characterization of enzyme specificity and efficiency under various experimental conditions. The sensitivity and reproducibility of fluorescence-based detection make it a preferred choice for both basic research and high-throughput screening applications.
Protease Inhibitor Screening: Methoxysuccinyl-Ala-Ala-Pro-Val-7-amino-4-trifluoromethylcoumarin serves as a valuable tool in the identification and evaluation of protease inhibitors. In drug discovery and biochemical research, the substrate is incorporated into screening assays where potential inhibitor compounds are tested for their ability to reduce or block enzymatic cleavage of the peptide. By monitoring changes in fluorescence output, scientists can rapidly assess inhibitor potency, selectivity, and mechanism of action, thereby accelerating the development of novel therapeutic agents targeting protease-mediated pathways. The substrate's high specificity for certain proteases ensures that off-target effects are minimized, increasing the reliability of screening outcomes.
Cellular and Molecular Biology Studies: The substrate's versatility extends to cellular and molecular biology applications, where it is used to investigate protease activity within complex biological samples such as cell lysates or tissue extracts. Incorporating MeOSuc-AAPV-AFC into these assays enables researchers to examine endogenous enzyme activity in response to various stimuli, treatments, or genetic modifications. This capacity to monitor proteolytic events in near-physiological contexts provides valuable insights into the regulation of proteases in health and disease, supporting the elucidation of molecular mechanisms underlying cellular processes such as inflammation, apoptosis, and tissue remodeling.
Biochemical Pathway Elucidation: Researchers employ this fluorogenic substrate to dissect and map protease-dependent biochemical pathways. By quantifying enzymatic activity in the presence or absence of specific modulators or cofactors, scientists can delineate the roles of individual proteases within larger signaling networks. The ability to track real-time changes in activity facilitates the identification of critical control points and feedback mechanisms, contributing to a comprehensive understanding of protease-driven biological functions. Such studies are essential for unraveling the complexity of proteolytic cascades involved in physiological and pathological processes.
Educational and Methodological Development: In addition to its research applications, MeOSuc-AAPV-AFC is frequently used in educational settings and for the development of novel methodological approaches. The clear, quantifiable fluorescence response provides an accessible platform for teaching fundamental concepts in enzymology, assay design, and data interpretation. Furthermore, the substrate is instrumental in the optimization of assay protocols, calibration of detection instruments, and validation of new analytical techniques, thereby supporting advancements in experimental biochemistry and molecular biology. Through these diverse applications, MeOSuc-AAPV-AFC continues to play a pivotal role in advancing protease research and methodological innovation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.